参考文献/References:
[1] Lindheim L,Bashir M,Münzker J,et al.Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome(PCOS):a pilot study[J].PLoS One,2017,12(1):e0168390.DOI:10.1371/journal.pone.0168390.
[2] Torres PJ,Siakowska M,Banaszewska B,et al.Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism[J].J Clin Endocrinol Metab,2018,103(4):1502-1511.DOI:10.1210/jc.2017-02153.
[3] Insenser M,Murri M,Del Campo R,et al.Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity[J].J Clin Endocrinol Metab,2018,103(7):2552-2562.DOI:10.1210/jc.2017-02799.
[4] Kelley ST,Skarra DV,Rivera AJ,et al.The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome[J].PLoS One,2016,11(1):e0146509.DOI:10.1371/journal.pone.0146509.
[5] Guo Y,Qi Y,Yang X,et al.Association between polycystic ovary syndrome and gut microbiota[J].PLoS One,2016,11(4):e0153196.DOI:10.1371/journal.pone.0153196.
[6] Le Chatelier E,Nielsen T,Qin J,et al.Richness of human gut microbiome correlates with metabolic markers[J].Nature,2013,500(7464):541-546.DOI:10.1038/nature12506.
[7] Karlsson FH,Tremaroli V,Nookaew I,et al.Gut metagenome in European women with normal, impaired and diabetic glucose control[J].Nature,2013,498(7452):99-103.DOI:10.1038/nature12198.
[8] Vrieze A,Van Nood E,Holleman F,et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J].Gastroenterology,2012,143(4):913-916.e7.DOI:10.1053/j.gastro.2012.06.031.
[9] Cotillard A,Kennedy SP,Kong LC,et al.Dietary intervention impact on gut microbial gene richness[J].Nature,2013,500(7464):585-588.DOI:10.1038/nature12480.
[10] Furet JP,Kong LC,Tap J,et al.Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers[J].Diabetes,2010,59(12):3049-3057.DOI:10.2337/db10-0253.
[11] Bäckhed F,Manchester JK,Semenkovich CF,et al.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice[J].Proc Natl Acad Sci U S A,2007,104(3):979-984.DOI:10.1073/pnas.0605374104.
[12] Ridaura VK,Faith JJ,Rey FE,et al.Gut microbiota from twins discordant for obesity modulate metabolism in mice[J].Science,2013,341(6150):1241214. DOI:10.1126/science.1241214.
[13] Martínez I,Lattimer JM,Hubach KL,et al.Gut microbiome composition is linked to whole grain-induced immunological improvements[J].ISME J,2013,7(2):269-280.DOI:10.1038/ismej.2012.104.
[14] Schirmer M,Smeekens SP,Vlamakis H,et al.Linking the human gut microbiome to inflammatory cytokine production capacity[J].Cell,2016,167(4):1125-1136. DOI:10.1016/j.cell.2016.10.020.
[15] Shorakae S,Teede H,de Courten B,et al.The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome[J].Semin Reprod Med,2015,33(4):257-269.DOI:10.1055/s-0035-1556568.
[16] Zhang D,Zhang L,Yue F,et al.Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation[J].Eur J Endocrinol,2015,172(1):29-36.DOI:10.1530/EJE-14-0589.
[17] Barr S,Hart K,Reeves S,et al.Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome[J].Eur J Clin Nutr,2011,65(10):1126-1132.DOI:10.1038/ejcn.2011.81.
[18] Louis P,Flint HJ.Formation of propionate and butyrate by the human colonic microbiota[J].Environ Microbiol,2017,19(1):29-41.DOI:10.1111/1462-2920.13589.
[19] Davila AM,Blachier F,Gotteland M,et al.Re-print of "Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host"[J].Pharmacol Res,2013,69(1):114-126.DOI:10.1016/j.phrs.2013.01.003.
[20] Chang AY,Lalia AZ,Jenkins GD,et al.Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome[J].Metabolism,2017,71:52-63.DOI:10.1016/j.metabol.2017.03.002.
[21] Pedersen HK,Gudmundsdottir V,Nielsen HB,et al.Human gut microbes impact host serum metabolome and insulin sensitivity[J].Nature,2016,535(7612):376-381.
[22] Han SI,Studer E,Gupta S,et al.Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes[J].Hepatology,2004,39(2):456-463.DOI:10.1002/hep.20043.
[23] Tomlinson E,Fu L,John L,et al.Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity[J].Endocrinology,2002,143(5):1741-1747.DOI:10.1210/endo.143.5.8850.
[24] Jia C,Xu H,Xu Y,et al.Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry[J].Mol Reprod Dev,2019,86(3):292-297.DOI:10.1002/mrd.23104.
[25] Wang D,Zhu W,Li J,et al.Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history[J].PLoS One,2013,8(11):e81190.DOI:10.1371/journal.pone.0081190.
[26] Arusoglu G,Koksal G,Cinar N,et al.Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive[J].J Clin Endocrinol Metab,2013,98(11):4475-4482.DOI:10.1210/jc.2013-1526.
[27] Moran LJ,Noakes M,Clifton PM,et al.Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition[J].J Clin Endocrinol Metab,2004,89(7):3337-3344.DOI:10.1210/jc.2003-031583.
[28] Zwirska-Korczala K,Sodowski K,Konturek SJ,et al.Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome[J].J Physiol Pharmacol,2008,59(Suppl 2):161-178.
[29] Heshmati J,Farsi F,Yosaee S,et al.The effects of probiotics or synbiotics supplementation in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized clinical trials[J].Probiotics Antimicrob Proteins,2018,[Epub ahead of print].DOI:10.1007/s12602-018-9493-9.
[30] Esmaeilinezhad Z,Babajafari S,Sohrabi Z,et al.Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: a randomized, triple blind, controlled trial[J].Nutr Metab Cardiovasc Dis,2019,29(2):201-208.DOI:10.1016/j.numecd.2018.07.002.
相似文献/References:
[1]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[2]黄爱洁,周莹,符金香,等.青春期多囊卵巢综合征的诊治进展[J].国际内分泌代谢杂志,2016,36(05):338.[doi:10.3760/cma.j.issn.1673-4157.2016.05.14]
Huang Aijie,Zhou Ying,Fu Jinxiang,et al.Diagnosis and treatment of polycystic ovary syndrome in adolescence[J].International Journal of Endocrinology and Metabolism,2016,36(05):338.[doi:10.3760/cma.j.issn.1673-4157.2016.05.14]
[3]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(05):270.
[4]顾子良 王洪东 朱大龙 毕艳.2型糖尿病治疗方法对肠道菌群的影响[J].国际内分泌代谢杂志,2018,38(04):254.[doi:10.3760/cma.j.issn.1673-4157.2018.04.009]
Gu Ziliang,Wang Hongdong,Zhu Dalong,et al.Effects of treatment of type 2 diabetes on gut microbiota[J].International Journal of Endocrinology and Metabolism,2018,38(05):254.[doi:10.3760/cma.j.issn.1673-4157.2018.04.009]
[5]高四书 王龙 华飞.晚期糖基化终末产物与多囊卵巢综合征的关系[J].国际内分泌代谢杂志,2018,38(04):279.[doi:10.3760/cma.j.issn.1673-4157.2018.04.015]
Gao Sishu,Wang Long,Hua Fei.Relationship between advanced glycation end-products and polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(05):279.[doi:10.3760/cma.j.issn.1673-4157.2018.04.015]
[6]陈俊秀 杜宏.肠道菌群与口服降糖药物[J].国际内分泌代谢杂志,2018,38(05):305.[doi:10.3760/cma.j.issn.1673-4157.2018.05.005]
Chen Junxiu*,Du Hong.Intestinal microbiota and oral hypoglycemic agents[J].International Journal of Endocrinology and Metabolism,2018,38(05):305.[doi:10.3760/cma.j.issn.1673-4157.2018.05.005]
[7]夏心怡 张洪梅.肠道菌群及其代谢产物调节糖脂代谢的机制[J].国际内分泌代谢杂志,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
Xia Xinyi,Zhang Hongmei.Regulating mechanism of glycolipid metabolism by intestinal microbiota and its metabolites[J].International Journal of Endocrinology and Metabolism,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
[8]周晓聪 张晓黎.益生菌与妊娠糖尿病的相关性[J].国际内分泌代谢杂志,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
Zhou Xiaocong,Zhang Xiaoli.Relationship between probiotics and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
[9]万仕炜 郁梅 方彭华 张真稳.小檗碱改善胰岛素抵抗的相关机制[J].国际内分泌代谢杂志,2018,38(05):333.[doi:10.3760/cma.j.issn.1673-4157.2018.05.012]
Wan Shiwei*,Yu Mei,Fang Penghua,et al.Related mechanism of berberine in improving insulin resistance[J].International Journal of Endocrinology and Metabolism,2018,38(05):333.[doi:10.3760/cma.j.issn.1673-4157.2018.05.012]
[10]张晓蕾 敖娜 都健.维生素D以肠道菌群为靶点治疗非酒精性脂肪性肝病的
研究进展[J].国际内分泌代谢杂志,2019,39(05):311.[doi:10.3760/cma.j.issn.1673-4157.2019.05.006]
Zhang Xiaolei,Ao Na,Du Jian.Advances in the treatment of non-alcoholic fatty liver disease with vitamin D targeting intestinal flora[J].International Journal of Endocrinology and Metabolism,2019,39(05):311.[doi:10.3760/cma.j.issn.1673-4157.2019.05.006]